The U.S. Food and Drug Administration (FDA) has given the okay to an app designed to help clinicians diagnose autism in children, labeling it safe for use. But it’s still unclear whether the technology is effective, researchers say, raising concerns that it could actually disrupt the standard diagnosis process and, in some cases, lead to delays in starting therapy.
Latest News Stories
- Vulnerable young adults to be given easier access to Child Trust Fund savings
- Speech and Language UK responds to GCSE overhaul putting speaking on a par with reading and writing
- Study finds gaps in breast cancer care for patients with a learning disability
- England win cerebral palsy World Cup for first time
- Mum wants grassroots football to be more inclusive
